Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.

Publication Type:

Journal Article

Source:

The Prostate, Volume 68, Issue 13, p.1477-86 (2008)

Keywords:

2008, Aged, Aged, 80 and over, Biological Markers, Body Mass Index, Case-Control Studies, Humans, Insulin-Like Growth Factor Binding Proteins, Insulin-Like Growth Factor I, Life Style, Logistic Models, Male, Middle Aged, Predictive Value of Tests, Prostatic Hyperplasia, Prostatic Neoplasms, Public Health Sciences Division, Risk Factors

Abstract:

We investigated whether peptides involved in cellular proliferation and apoptosis, [insulin-like growth factor I (IGFI) and its major binding protein (insulin-like growth factor binding protein 3)], predicted risk of benign prostate hyperplasia (BPH).